Sept 26 (Reuters) - Baxter International Inc :
* Baxter launches first 3-in-1 set for use in continuous renal replacement therapy and sepsis management protocols
* Baxter International Inc - announced commercial launch of a new indication for company’s oXiris set
* Baxter International Inc - Baxter currently plans to file for expanded indication for oXiris set in additional countries in 2018 and beyond Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.